Genomic Testing Cooperative to Present at 2026 ASCO Annual Meeting
The Genomic Testing Cooperative (GTC) will exhibit and present its research at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. GTC will showcase its DNA and RNA-based precision oncology testing, focusing on applications in hematologic malignancies, breast cancer metastasis, and central nervous system involvement. The meeting, which runs from May 29 to June 2, 2026, will feature over 3,400 abstracts, highlighting significant advancements in cancer research and treatment. GTC aims to connect with media, oncology leaders, and potential partners to discuss its comprehensive testing platform and cooperative business model. 
